Related Experiment Video
Updated: May 8, 2026
11:49
Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
Published on: March 8, 2019
Physical stability of urea topical formulations
International Journal of Pharmaceutical Compounding
|August 31, 2013
Summary
This study examined the physical stability of urea in various dermatological bases. Carbopol and Carbopol-Velvachol combinations showed the best stability for urea formulations.
Area of Science:
- Dermatology
- Cosmetic Science
- Pharmaceutics
Background:
- Urea is a common dermatological agent used in concentrations up to 40% for various skin conditions.
- Understanding the physical stability of urea in different topical formulations is crucial for effective drug delivery and product shelf-life.
Purpose of the Study:
- To evaluate the physical stability and characteristics of urea incorporated into multiple dermatological vehicles.
- To identify optimal vehicle bases for high-concentration urea formulations.
Main Methods:
- Urea was incorporated into ten different dermatological vehicles and vehicle combinations at concentrations ranging from 10% to 40%.
- Physical characteristics and apparent stability of the resulting preparations were systematically observed and assessed.
Main Results:
- Preparations containing Carbopol exhibited favorable physical characteristics and apparent stability.
- Combinations of Carbopol with Velvachol also demonstrated excellent observable characteristics and physical stability for urea formulations.
Conclusions:
- Carbopol and Carbopol-Velvachol combinations are suitable bases for formulating stable, high-concentration urea preparations.
- These findings can guide the development of more effective and stable topical urea treatments.
Related Concept Videos
01:16Drug Product Stability
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:18Urine: Physical and Chemical Properties
Urine comprises approximately 95% water and 5% solutes. The primary ingredient, apart from water, is urea - a byproduct of the breakdown of amino acids. Other notable components include uric acid, a residue from nucleic acid metabolism, and creatinine, a metabolite from creatine phosphate breakdown in skeletal muscle tissue.
The concentration of these solutes varies, with urea being the most abundant nitrogenous waste product. Other solutes include sodium, chloride, potassium, phosphate,...
The concentration of these solutes varies, with urea being the most abundant nitrogenous waste product. Other solutes include sodium, chloride, potassium, phosphate,...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...